NCT04656236View on ClinicalTrials.gov

Metabolic Effects of Exogenous 3-hydroxybutyrate in Patients With Type 1 Diabetes and Healthy Controls

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

March 1, 2022

Study Completion Date

March 1, 2022

Conditions

Type 1 Diabetes MellitusDiabetic Ketoacidosis

Interventions

BIOLOGICAL

3-hydroxybutyrate

3-hydroxybutyrate is a metabolite, produced in the human body.

Trial Locations (1)

8000

Steno diabetes center Aarhus, Aarhus

All Listed Sponsors

collaborator

Aarhus University Hospital

OTHER

lead

University of Aarhus

OTHER

NCT04656236 - Metabolic Effects of Exogenous 3-hydroxybutyrate in Patients With Type 1 Diabetes and Healthy Controls | Biotech Hunter | Biotech Hunter